cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B

Chronic hepatitis B virus infection (CHB) remains a global health concern, with currently available antiviral therapies demonstrating limited effectiveness in preventing hepatocellular carcinoma (HCC) development. Two primary challenges in CHB treatment include the persistence of the minichromosome,...

Full description

Bibliographic Details
Main Authors: Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Annals of Hepatology
Subjects:
covalently closed circular DNA
chronic hepatitis B
epigenetic
immune response
therapeutic vaccine
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124003272

Internet

http://www.sciencedirect.com/science/article/pii/S1665268124003272

Similar Items